In particular, participants with serum albumin levels in the highest quartile had a 51% lower likelihood of having MetS compared to those in the lowest quartile (OR: 0.49; 95% CI: 0.43–0.55; P < 0.001). The gene discussed is ALB; the disease is metabolic syndrome.